Skip to content

The Prognostic Role of Tumor-Infiltrating T Lymphocytes in Stage II-III Colorectal Cancer

The Prognostic Role of Tumor-Infiltrating T Lymphocytes in Stage II-III Colorectal Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107594
Enrollment
Unknown
Registered
2025-08-14
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

observation group:None

Sponsors

The first affiliated hostipal of nanchang university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed primary colorectal cancer after surgical resection; 2.Pathological stage II (pT3-4aN0M0) or stage III (any pT, pN1-2M0) according to the AJCC/UICC 8th edition. 3.with complete clinicopathological data; 4.underwent radical surgical resection; 5.with available formalin-fixed paraffin-embedded (FFPE) tumor tissue blocks or high-quality slides; 6.Pathologically confirmed colorectal cancer after surgical resection.

Exclusion criteria

Exclusion criteria: 1.Patients who received neoadjuvant therapy (chemoradiotherapy/targeted therapy/immunotherapy); 2.with severely missing clinicopathological or follow-up data; 3.Poor-quality tissue samples; 4.Patients with a history of other malignant tumors or synchronous/metachronous colorectal cancers.

Design outcomes

Primary

MeasureTime frame
Overall survival (OS);disease-free survival (DFS);

Countries

China

Contacts

Public ContactJiang Qunguang

The first affiliated hostipal of nanchang university

fbron.student@sina.com+86 18170089570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026